Egide (ALGID) H1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 TU earnings summary
30 Jul, 2025Executive summary
Consolidated revenue for H1 2025 reached €15.6M, up 1% year-over-year, marking a return to growth after a challenging 2024.
Strong performance in thermal imaging and new applications, driven by successful diversification.
Growth in Europe (+53%) and stable position in North America offset declines in Asia due to geopolitical factors.
Financial highlights
Egide SA revenue grew 11% year-over-year to €7.81M; Egide USA up 10% to €5.67M; Santier declined 36% to €2.08M.
Thermal imaging revenue surged 59% to €6.8M, now 44% of total revenue.
Power and RF/MW segments declined by 32% and 37% respectively.
New applications (thermal batteries, firing systems) grew 9%, now 14% of revenue.
Outlook and guidance
H2 2025 revenue expected to slightly exceed H1, confirming gradual recovery and growth trajectory.
Continued focus on diversifying customer base and strengthening presence in defense and aerospace.
Latest events from Egide
- 2025 revenue rose 4% to €31.34m, driven by thermal imaging and European market gains.ALGID
H2 2025 TU26 Jan 2026 - EBITDA turned positive as revenue rose 1%, but net loss widened due to Santier’s downturn.ALGID
H1 202522 Oct 2025 - 2024 revenue dropped 15.5%, but single-digit growth is forecast for 2025.ALGID
H2 202410 Sep 2025 - H1 2024 sales dropped 19%, but a €1.8M capital increase aims to support future growth.ALGID
H1 202413 Jun 2025 - 2024 revenue fell 15.5%, but single-digit growth is forecast for 2025.ALGID
H2 2024 TU6 Jun 2025